Stemtech

Stemtech Debt/Market Cap

The Debt to Market Capitalization Ratio of Stemtech (STEK) as of Oct 31, 2026 is 1,539.34 %. In the previous year, Debt to Market Capitalization Ratio was 2,083.82 % — a change of -26.13% (lower).

Debt/Market Cap

1,539.34 %

YoY

-26.13%

Last updated:

Debt to Market Capitalization Ratio of Stemtech is 2022 1,539.34 % . Debt to Market Capitalization Ratio of Stemtech was 2021 2,083.82 % . It decreases by -26.13% lower compared to the previous year.

The Stemtech Debt/Market Cap history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt/Market Cap
Date
Debt/Market Cap
Jan 1, 2014
43.11 USD
Jan 1, 2017
146.33 USD
Jan 1, 2018
43.11 USD
Jan 1, 2019
191.88 USD
Jan 1, 2020
1,276.85 USD
Jan 1, 2021
2,083.82 USD
Jan 1, 2022
1,539.34 USD
The Stemtech Debt/Market Cap history
YEARDebt/Market CapYoY
1,539.34 %-26.13%
2,083.82 %+63.20%
1,276.85 %+565.45%
191.88 %+345.11%
43.11 %-70.54%
146.33 %+239.44%
43.11 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Stemtech Stock analysis

What does Stemtech do? Stemtech Corp develops nutritional supplements that support stem cell activity, marketed internationally through subsidiaries and independent distributors. The company's products include the RCM System, stemrelease3, Stemflo MigraStem, OraStem for oral health, and D-Fuze for electromagnetic frequency blocking. Cellect One Rapid Renew Stem Cell Peptide Night Cream is its skincare offering. Products are sold in North America, Latin America, and Asia through distributors and subsidiaries. The firm's brands target health-conscious consumers seeking stem cell support, with OraStem focusing on oral care and D-Fuze addressing electromagnetic frequency concerns. Independent distributors handle sales across all segments, leveraging the company's international presence. The RCM System and stemrelease3 are core products for general stem cell enhancement. Stemtech Corp's revenue streams come from direct sales of its branded nutritional supplements and skincare products. Distributors purchase products from subsidiaries to resell, generating consistent income through these channels. The company's international segments ensure diverse market coverage without relying on a single region. Stemtech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Stemtech stock

Debt to Market Capitalization Ratio of Stemtech is 1,539.34 % in 2022.

Debt to Market Capitalization Ratio of Stemtech changed from 2,083.82 % to 1,539.34 %, representing a -26.13% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Debt to Market Capitalization Ratio Stemtech since 2006 – with annual values, charts, and detailed analysis.

Debt/Market Cap compares total debt to the market value of equity. It provides a market-based view of financial leverage.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Debt to Market Capitalization Ratio's Stemtech with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Stemtech

All Key Metrics — Stemtech